If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDfs Furniture Plc Regulatory News (DFS)

Share Price Information for Dfs Furniture Plc (DFS)

Share Price is delayed by 15 minutes
Get Live Data
135.00    0.00 (0.00%)
Bid:
134.50
Ask:
135.00
Spread: 0.50 (0.372%)
Market Cap: £312.54m
DFS Live PriceLast checked at - London Stock Exchange

Intraday Dfs Furniture Plc Share Chart

£250M NEW CREDIT FACILITIES SIGNED

7 Sep 2023 07:00

RNS Number : 6275L
DFS Furniture PLC
07 September 2023
 

7 September 2023

DFS FURNITURE PLC

£250M NEW CREDIT FACILITIES SIGNED

 

DFS Furniture plc ("DFS" and the "Group"), the market leading retailer of living room and upholstered furniture in the United Kingdom, is pleased to announce the successful completion of a new £200m Revolving Credit Facility ("RCF") and £50m issue of US Private Placement ("USPP") notes. Together, these replace the existing £215m RCF.

The £200m RCF which has been agreed with existing banking partners, will mature in September 2027 and includes an option to extend a further 16 months subject to lenders' agreement. The terms of the RCF are in line with the previous £215m facility and are consistent with those applicable to the £50m USPP notes. The notes will mature in September 2028 (£25m) and September 2030 (£25m).

John Fallon, the Group's Chief Financial Officer, said "The successful renewal of our lending facilities is a strong positive endorsement of the confidence the Group maintains with our long term banking partners and the wider credit market. It provides additional liquidity over the longer term as well as flexibility to pursue all our strategic objectives."

 

Enquiries:

DFS (enquiries via Tulchan)

John Fallon (Group CFO)

Liz McDonald (Company Secretary)

Phil Hutchinson (Investor Relations)

investor.relations@dfs.co.uk

 

Tulchan

James Macey-White

Jessica Reid

+44 (0)20 7353 4200

dfs@tulchangroup.com

 

About DFS Furniture plc

The Group is the clear market-leading retailer of living room furniture in the United Kingdom. Our Group purpose is to bring great design and comfort into every living room, in an affordable, responsible and sustainable manner. We operate an integrated physical and digital retail network of living room furniture showrooms and web sites in the United Kingdom and Republic of Ireland, trading through our leading brands, DFS, Sofology and Dwell. We attract customers through our targeted and national marketing activities and our reputation for high quality products and service, breadth of product offer and favourable consumer financing options. We fulfill orders for our exclusive product ranges through our own three UK finished goods factories, and through manufacturing partners located in the UK, Europe and Far East, and delivered with care through our expert final-mile delivery service "The Sofa Delivery Company Limited".

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUNRBROAUKRAR
Date   Source Headline
7th Jul 20264:57 pmRNSHolding(s) in Company
16th Jun 20269:49 amRNSHolding(s) in Company
20th May 20264:31 pmRNSHolding(s) in Company
6th May 20267:00 amRNSDirectorate change
30th Apr 20267:00 amRNSPurchase of shares by Employee Benefit Trust
1st Apr 20263:06 pmRNSEBT Update
19th Mar 20267:00 amRNSInterim Results
20th Jan 20267:00 amRNSTrading Statement
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSTotal Voting Rights
8th Dec 20251:40 pmRNSTotal Voting Rights
17th Nov 20257:00 amRNSDirector/PDMR Shareholding
14th Nov 20254:17 pmRNSDirectorate change
14th Nov 20253:47 pmRNSResult of AGM
14th Nov 20257:00 amRNSAGM Trading Statement
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
23rd Oct 20251:19 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSDirector/PDMR Shareholding
20th Oct 202510:35 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSDirector/PDMR Shareholding
14th Oct 20257:00 amRNSAnnual Financial Report
25th Sep 20257:00 amRNSFY25 Preliminary Results
12th Aug 20258:00 amRNSDirector Declaration
17th Jul 20257:00 amRNSTrading Statement
13th May 202511:59 amRNSHolding(s) in Company
10th Apr 202512:46 pmRNSInvestor Presentation via Investor Meet Company
9th Apr 202511:29 amRNSDirectorate Change
4th Apr 202510:37 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSInterim Results
24th Feb 20257:00 amRNSDirectorate Change
12th Feb 20251:15 pmRNSChange of Adviser
7th Feb 20253:14 pmRNSHolding(s) in Company
5th Feb 20259:28 amRNSHolding(s) in Company
29th Jan 20257:00 amRNSDirectorate Change
17th Jan 20257:00 amRNSTrading Statement
8th Jan 202512:05 pmRNSHolding(s) in Company
7th Jan 202512:34 pmRNSHolding(s) in Company
6th Jan 20252:47 pmRNSHolding(s) in Company
3rd Jan 20252:17 pmRNSHolding(s) in Company
13th Dec 20247:00 amRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSHolding(s) in Company
27th Nov 20247:00 amRNSValidation of SBTi Targets
25th Nov 202411:52 amRNSHolding(s) in Company
25th Nov 202410:57 amRNSHolding(s) in Company
22nd Nov 20243:31 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.